Archive for April 2016

Illinois Doctor Has Medical License Suspended Over Purchase of Fake Cancer Drugs

Dr. Ann Kinnealey can no longer practice medicine in Illinois after a hearing by the Illinois State Medical Board determined that she purchased misbranded cancer medication from foreign supplier, Quality Specialty Products (QSP). QSP was a wholesale subsidiary of Canadian Internet Pharmacy giant, CanadaDrugs. Dr. Kinnealey had her 2 medical licenses suspended on April 21…

[...]

How Fake Drug Importer Gallant Pharma’s D.C. Address Gave it a Veneer of Legitimacy

Though their medication it sold was neither FDA-approved nor legally imported, Gallant Pharma was able to pass itself off as a legitimate pharmaceutical supplier simply by basing their operation in a Washington D. C. suburb, and claiming their drugs were sourced from Canada. When the Department of Justice (DOJ) originally announced the indictment of 11…

[...]

Florida Businessman Sentenced in Counterfeit Drug Distribution Case

A Tampa Federal court has sentenced Robert Lohr to 21 months in federal prison for conspiracy to smuggle misbranded and counterfeit drugs into the United States. He was also required to forfeit over $900,000 in profits. He had pleaded guilty in January. Lohr operated a business called “Canadian American Drug Club” or “American Drug Club…

[...]

Minnesota Night Market Raided, Counterfeit and Misbranded Drugs Seized

Ramsey County Sheriffs in Saint Paul Minnesota conducted an investigation of vendors at an area Hmong night market and discovered counterfeit medication for sale by 2 different vendors. Sheriffs discovered pills, needles, syringes and expired medication during their investigation. Who: Ramsey County Sheriff’s Department. When: April 4, 2016, 2013 – 2016. Where: Saint Paul, Minnesota.…

[...]

Urogynecologic Surgical Mesh Implants by Boston Scientific: Notification – Potential for Counterfeit Raw Material

This is a reprint of an FDA Alert. [Posted 04/01/2016] AUDIENCE: Surgery, OB/GYN, Risk Manager ISSUE: The FDA is aware of allegations that Boston Scientific’s urogynecologic surgical mesh may contain counterfeit raw material. We are examining these allegations to determine any necessary and appropriate next steps. FDA is not currently aware that the alleged counterfeit…

[...]